Endocrine-disrupting chemicals may raise risk of cognitive disorders in future generations, animal study finds

Adverse cognitive effects linked to polychlorinated biphenyls (PCBs) exposure, a type of endocrine-disrupting chemical (EDC), have the potential to be passed down through generations, according to an animal study being presented Thursday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.

Mount Sinai Researchers Use Artificial Intelligence to Uncover the Cellular Origins of Alzheimer’s Disease and Other Cognitive Disorders

Deep learning models represent “an entirely new paradigm for studying dementia”

Ochsner Health Receives $700K Dementia Care Grant from the National Institute on Aging and National Institutes of Health

The National Institute on Aging (NIA) and the National Institutes of Health (NIH) awarded Ochsner Health a $700,000 grant to study the effectiveness of its collaborative dementia care through the Ochsner Neuroscience Institute’s Brain Health and Cognitive Disorders Program.